Your browser doesn't support javascript.
loading
A Novel Oncogenic Driver in a Lung Adenocarcinoma Patient Harboring an EGFR-KDD and Response to Afatinib.
Chen, Dong; Li, Xing-Liang; Wu, Biao; Zheng, Xiao-Bin; Wang, Wen-Xian; Chen, Hua-Fei; Dong, Yi-Yu; Xu, Chun-Wei; Fang, Mei-Yu.
Afiliación
  • Chen D; Department of Pathology, Zhejiang Rongjun Hospital, Jiaxing, China.
  • Li XL; Department of Tumor Molecular Laboratory, Zhejiang Rongjun Hospital, Jiaxing, China.
  • Wu B; Department of Medical Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China.
  • Zheng XB; Department of Medical Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China.
  • Wang WX; Department of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou, China.
  • Chen HF; Department of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, Jiaxing, China.
  • Dong YY; Department of Tumor Molecular Laboratory, Zhejiang Rongjun Hospital, Jiaxing, China.
  • Xu CW; Department of Pathology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China.
  • Fang MY; Department of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou, China.
Front Oncol ; 10: 867, 2020.
Article en En | MEDLINE | ID: mdl-32656077
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2020 Tipo del documento: Article